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1. Introduction 
As in most other tissues [2-6,10,12,14,17,18, 
21-23,2&27,30,32,36,37];review [35],mammalian 
brain acetylcholinesterase exists in several molecular 
forms [1,7,15,16,19,20,24,29,31,33,34,38-40]. 
Depending on the method of extraction of the enzyme 
between 2 and 4 forms have been detected in the rat 
brain [ 1 ,15,24,29,3 1,34,38,40] either by gel filtration 
or sucrose gradient centrifugation or polyacrylamide 
gel electrophoresis. It is generally assumed that the 
various forms are different states of aggregation of a 
single monomer (review [39]) but no clear proof has 
been reported of this hypothesis for the rat brain 
enzyme. In [29], we compared by gel filtration and 
sucrose gradient centrifugation the membrane-bound 
molecular species of the rat brain AChE with the vari- 
ous ‘soluble’ species and reported that the structural 
relationships as well between the membrane-bound 
enzyme and the 3soluble species as between the 3 sol- 
uble species are not evident. This paper describes the 
preparation of a monospecific antibody against the 
purified membrane-bound enzyme [28] which allows 
further progress in this research and permits the study 
of possible cross immunoreactivity between the sol- 
uble and the membrane-bound species of rat brain 
AChE. 
2. Materials and methods 
Separation of ‘soluble’ and ‘membrane-bound’ 
AChE: All operations were performed at 4°C. Adult 
rat brains were homogenized in 10 vol. 12.5 mM 
sodium phosphate buffer (pH 7.4) containing 0.4 M 
NaCl and the suspension was centrifuged for 2 h at 
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100 000 X g. The supernatant was used as the source 
of ‘soluble’ AChE. The pellet was dissolved in 100 ini- 
tial vol. of the same buffer containing 0.5% Triton 
X-100 [28] and the suspension was centrifuged. This 
supernatant was used as the source of the ‘membrane- 
bound’ AChE. 
The membrane-bound enzyme was purified by 
sequential ffinity chromatography on con A- 
Sepharose (Pharmacia, Uppsala) and mdimethyi- 
aminoethyl benzoic acid (DMAEBA) coupled to 
Sepharose 4B as in [28]. After DEAE-cellulose chro- 
matography and a second affinity chromatography on 
DMAEBA-Sepharose, the membrane-bound enzyme 
was found to be pure and homogenous [28]. This 
material was used for immunizing the rabbit. The ‘sol- 
uble’ enzyme was partially purified using affinity 
chromatography oncon A-Sepharose and DMAEBA- 
Sepharose in the absence of detergent. This enzyme 
was also used for immunodiffusion and immunopre- 
cipitation . 
Antibodies were raised in a rabbit by three succes- 
sive injections at 15 day intervals of 200 l.(g protein 
antigen as follows: 
- The antigen dissolved in 500-p 0.5% Triton X-100 
was mixed with 500/11 complete Freund’s adjuvant 
and injected intradermically in the back of the 
rabbit; 
- For the second injection, the same procedure was 
used except that incomplete Freund’s adjuvant was 
added to the antigen; 
- For the third injection, the antigen was adsorbed 
on alumina [8] and injected intravenously inthe ear. 
The serum obtained from the rabbit was partially 
purified using repetitive ammonium sulfate precipita- 
tions [9]. This fraction wascalled ‘Ig fraction’ and 
was used in all our studies. 
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The antiserum was tested against purified AChE 
by double immunodiffusion in 1% agarose (Industrie 
Biologique Francaise, Paris) in 70 mM Tris-barbitone 
buffer (pH 8.6) containing 0.01% (w/v) calcium lac- 
tate, 0.02% (w/v) sodium azide and 0.1% (w/v) Triton 
X-100. Diffusion was performed for 25 days at 4°C. 
The gels were washed alternately with 0.5% Triton 
X-l 00 solution containing 0.4 M NaCl then water (10 
times for 30 mm) and stained either with Coomassie 
brillant blue R for protein or by the method in [ 131 
for esterasic activity. 
Crossed immunoelectrophoresis was performed 
under the same conditions: the antigen was run for 
24 h in the first direction at 15 V/cm. Electrophoresis 
in the second direction in a gel containing a l/60-fold 
dilution of the Ig fraction was performed for 72 h at 
5 V/cm. Gels were washed and stained as above. 
In vitro immunoprecipitation: For these experi- 
ments both ‘crude’ and ‘partially purified’, soluble 
and membrane-bound enzymes were used. A typical 
assay contained 100 ~1 enzyme in 12.5 mM sodium 
phosphate buffer (pH 7.2) containing 0.9% NaCl 
(PBS), 100 ~1 Triton X-100 (3% w/v) and 100 ~1 
diluted Ig in PBS. The mixture was incubated for 24 h 
at 4°C and centrifuged for 1 h at 30 000 X g. Both 
supernatant and pellet were analysed for AChE activity 
as in [ 1 l] using lo-’ M 1,5-bis-(4allyldimethylam- 
monium phenyl) pentane3one dibromide (Sigma, 
St Louis MO) as specific inhibitor. In most cases, ali- 
quots of the supernatant were incubated with 100 ~1 
sheep anti-rabbit immunoglobulins (24 h at 4’C) and 
centrifuged as above. AChE was determined both in 
the pellet and the supernatant. 
Blanks were performed using Ig obtained from 
rabbits not immunized with AChE or with anti-AChE 
Ig without enzyme. This blank is necessary for taking 
into account the low AChE activity present in the 
rabbit Ig fraction. 
3. Results and discussion 
As shown in fig.1, the antibody against the mem- 
brane-bound AChE gives only one precipitation line 
either with the purified or with the crude membrane- 
bound enzyme, either with a protein stain (fig.la) or 
a specific enzyme stain (fig.1 b). By crossed immuno- 
electrophoresis (Bg.2), two peaks can be detected. 
However the slowly migrating one is found even if the 
second dimension is run in a gel not containing the 
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Fig.1. Double immunodiffusion test in the presence of Triton 
X-100 of the antibody raised against he membrane-bound 
rat brain acetylcholinesterase. (a) Coomassie brillant blue 
stain: the membrane-bound enzyme is placed in the centre 
well; various dilutions of the antibody are placed in wells 1,2, 
3,6 and normal rabbit serum in wells 4 J. 
(b) Enzyme stain: the membrane-bound enzyme is placed in 
centre well, dilutions of antibody in wells 2-4 and dilu- 
tions of non-immunized rabbit serum in wells 1,s ,6. 
(c) Enzyme stain [13]: the antibody is placed in the centre 
well. Well 6: purified membrane-bound AChE; well 4: 
total rat brain AChE; well 2: partially purified soluble 
AChE (same activity as in well 6). 
(d) Enzyme stain [ 181: the antibody is placed in the centre 
well. Well 1,2,3,4: dilution of the partially purified solu- 
ble AChE. Note the absence of any precipitation lines. 
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Fig.2. Crossed immunoelectrophoresis of the membrane- 
bound ACItE. Horizontal first electrophoresis run in gel with- 
out antibody. Vertical: second run in gel containing the anti- 
body. An artefactual precipitate is observed close to the limit 
of the two gels (double arrow). 
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antibody. This precipitation of a part of the enzyme 
at the boundary between the two agarose gels seems 
thus to be artefactual and may correspond to enzyme 
denaturation. 
The pattern obtained with the soluble enzyme is 
completely different (fig.lc,ld). We never observed 
any precipitation lines between this material and our 
antibody against the membrane-bound enzyme even 
if the soluble antigen is run in the presence of Triton 
X-100. The absence of precipitation does not result 
from the presence of little antigen, since no precipita- 
tion occurs with the ‘partially purified’ enzyme 
(12 OOO-fold purification) when equivalent activities of 
soluble and membrane-bound enzymes are employed 
for the immunodiffusion test. This cannot be explained 
by the complete denaturation of the soluble enzyme 
during diffusion since enzyme activity is found around 
the corresponding wells when the immunodiffusion 
gels are not washed. 
The antibody against the membrane-bound AChE 
precipitated the crude or the purified membrane- 
bound enzyme solubilized in the presence of Triton 
X-100 (fig3a)No precipitation occurs with the serum 
of non-immunized rabbits under identical conditions. 
Addition of sheep anti-rabbit immunoglobulin 
increases the enzyme precipitation (fig.3a). When the 
partially purified soluble AChE or the crude soluble 
AChE from rat brain was treated under the same con- 
ditions (in presence of Triton X-100) no precipitation 
occurred (fig3b). 
As found with AChE from other tissues [ 1,16,23, 
381, specific antibodies inhibited the activity of the 
membrane-bound AChE: up to 60% of the activity is 
lost during these experiments of precipitation with 
antibodies but not with sera of non-immunized rabbits. 
Such an inhibition does not occur with the soluble 
AChE (fig3b). 
These experiments indicate clearly that our anti- 
body against the purified membrane-bound AChE 
from rat brain does not react on the species of AChE 
which are soluble in the absence of detergent [ 1,291. 
The results in [38] where only 80% of the total AChE 
activity found in rat brain can be precipitated by anti- 
bodies against AChE prepared from mouse brain [l] 
can be interpreted by a lack of reactivity of a part of 
AChE. The lack of immunological reactivity could be 
intrepreted in two ways: 
(i) The ‘soluble’ and ‘membrane-bound’ AChE from 
rat brain are completely different molecules; 
a 
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Fig.3. In vitro immunoprecipitation of the membrane-bound 
(fig.3a) and the ‘soluble’ (fig.3b) AChE from adult rat brain. 
Abscissae: -log (antibody concentration). Ordinates: percent 
of initial enzyme activity. Activity in the supernatant (=) and 
in the pellet (0) after incubation with anti-AChE. Activity in 
the supernatant (0) and in the pellet (0) after incubation with 
anti-AChE then anti-rabbit lg. 
(ii) These two kinds of AChE represent associations 
of the same monomer with very different confor- 
mations and (or) different degrees of association. 
The fmdings in [29] that ‘soluble’ and membrane- 
bound AChE behave differently by filtration and 
sucrose gradient centrifugation and also differ in their 
behaviour with respect to reducing agents [29] might 
favour the first hypothesis but can not be taken as a 
proof of it. Work is now in progress to isolate the dif- 
ferent species of soluble AChE [29] to see if the 
monomer corresponds to that of the membrane-bound 
enzyme [28]. 
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